Inactive Instrument

HEXO Corp. Stock

HEXO

CA4283043079

Analysts' recommendations: HEXO Corp.

09/04/25	Piper Sandler on Tilray: Canadian Cannabis Still Pressured, Guidance Lowered	MT
31/07/24	Piper Sandler On Tilray; Neutral Rating and US$2 Target; Says "Focus Now On Germany To Drive Growth"	MT
16/06/23	Canaccord Genuity Trims HEXO's Price Target to CA$1 From CA$1.50, Maintains Hold Rating	MT
16/12/22	CIBC Upgrades HEXO to Neutral From Underperform	MT
16/06/22	Canaccord Genuity Downgrades HEXO to Hold From Speculative Buy, Adjusts Price Target to CA$0.25 From CA$1	MT

More recommendations

News in other languages: HEXO Corp.

24/03/23	HEXO figure au classement de la 4e référence Women Lead Here du journal The Globe and Mail pour la diversité des genres au sein des directions d’entreprise
17/03/23	HEXO publie les résultats financiers du 2T2023
14/03/23	HEXO tiendra une conférence téléphonique sur les résultats financiers du deuxième trimestre 2023
08/02/23	HEXO annonce une augmentation de la production de ses populaires joints droits préroulés et le lancement d’une technologie d’inhalation améliorée
01/02/23	HEXO annonce l’élection des administrateurs

More news

Managers and Directors: HEXO Corp.

Manager	Title	Age	Since
Carl Merton CEO	Chief Executive Officer	57	22/06/2023
Pamela McRae CTO	Chief Tech/Sci/R&D Officer	-	-
Richard Redekop COO	Chief Operating Officer	-	15/06/2022

Director	Title	Age	Since
Vincent Chiara BRD	Director/Board Member	-	04/11/2016
Peter Montour BRD	Director/Board Member	-	30/08/2021
William Montour BRD	Director/Board Member	-	05/01/2022

More insiders

Hexo Corp. is a Canada-based consumer packaged goods cannabis company. The Company is engaged in cultivating, processing, packaging, and distributing cannabis products to serve the cannabis market. The Company serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market in Canada and Israel. Its HEXO brand offers a range of flower strains, discreet capsules, and convenient vapes, including the HEXO FLVR lineup of flavor-first vapes.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
HEXO Stock

As early as today, start finding the best investment opportunities!

11-24	Tilray Brands Brief: Unveiling Good Supply Vapes in Quebec Following Recent Introduction of Vape Products in That Province	MT
30/10/25	Tilray Brands Brief: Setting Sights on Asia; Bringing Craft Beers to Japan Festival	MT
09/10/25	Tilray Brands Brief: Reiterating Fiscal Year 2026 Adjusted EBITDA Outlook of US$62 Million-$72 Million	MT
09/10/25	Tilray Brands Brief: Says Balance Sheet Strengthened to US$265 Million in Cash; Adds Net Debt Reduced to $4 Million	MT
09/10/25	Tilray Brands Brief: Q1 Net Income of US$1.5 Million	MT
09/10/25	Tilray Brands Brief: Record Q1 Net Revenue of US$210 Million	MT
30/09/25	Tilray Expands German Cannabis Portfolio With Five New Products	MT
30/09/25	Tilray Brief: Also, Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings	MT
30/09/25	Tilray Brief: Announcing Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany	MT
03/09/25	Tilray Brief: Breckenridge Distillery Expanding California Distribution with Winebow	MT
28/08/25	Tilray Brief: Expanding Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains	MT
28/08/25	Tilray Brief: Says Regained Compliance with Nasdaq's Minimum Bid Price Requirement	MT
14/08/25	Tilray Requests Extension to Meet Nasdaq Listing Requirements	MT

13/10/23	From high flying to burnout, pot industry faces downturn five years post-legalization	AQ
18/09/23	Entourage Health Announces Amendment to Key Supply Agreement	AQ
23/06/23	HEXO Corp. Announces Completion of Acquisition by Way of Arrangement With Tilray Brands, Inc.	BU
19/06/23	HEXO Corp. Announces Receipt of Final Order for Arrangement With Tilray Brands, Inc.	BU
15/06/23	HEXO: Fiscal Q3 Earnings Snapshot	AQ

Date	Insider	Type	Main position	Quantity	% Market Cap.
5/2/23 A	Robin Godfrey	Other	Director	0	0%
4/28/23 A	Hélène Fortin	Option	Director	8,117	0.0189%
4/28/23 A	Charles Bowman	Tax	Chief Executive Officer	3,184,422	7.4181%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
HEXO CORP.	-16.59%	-39.87%	-	-	29.39M
ELI LILLY AND COMPANY	+3.55%	+7.01%	+51.42%	+105.45%	1,116B
JOHNSON & JOHNSON	-0.25%	-1.25%	+32.49%	+61.48%	610B
ABBVIE INC.	-0.03%	+4.03%	+25.28%	+91.54%	501B
MERCK & CO., INC.	-1.48%	+1.97%	+72.62%	+39.59%	358B
ROCHE HOLDING AG	-0.74%	+5.37%	+32.14%	+49.51%	366B
NOVARTIS AG	-1.14%	+4.67%	+19.47%	+42.96%	288B
ASTRAZENECA PLC	-1.78%	+4.25%	-0.37%	+14.00%	261B
AMGEN INC.	+1.86%	+6.53%	+45.98%	+52.77%	235B
GILEAD SCIENCES, INC.	+2.49%	+6.98%	+33.03%	+102.67%	195B
Average	-1.39%	+5.27%	+34.67%	+62.22%	436.64B
Weighted average by Cap.	+0.81%	+4.93%	+38.27%	+71.70%

HEXO Corp. Stock

Stocks

HEXO

CA4283043079

Pharmaceuticals

Latest news: HEXO Corp.

Analysts' recommendations: HEXO Corp.

Press Releases: HEXO Corp.

News in other languages: HEXO Corp.

Quotes and Performance

Managers and Directors: HEXO Corp.

Latest insider transactions

Recreational Pharmaceuticals

Company Profile